Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07301710

Low-Tech Treatments for Obstructive Sleep Apnea

The overall purpose of this study is to compare changes in sleep outcomes in people with obstructive sleep apnea (OSA) depending on their participation in one of two behavioral interventions; both involve drinking water and breathing. A second purpose is to compare outcomes between people who have sustained a traumatic brain injury (TBI) and those with no history of TBI. The main questions it aims to answer are whether sleep quality improves after 3-months of high-resistance versus low-resistance exercises, and whether people have different outcomes depending on their history of TBI.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Walter Reed National Military Medical Center

Bethesda, Maryland, 20889, United States

Location status: Recruiting

Location contact

Kathleen M. Moran, Ed.D.

CONTACT

[email protected]

574-344-8933 ext. 443-776-1689

Kent Werner, MD, PhD

PRINCIPAL_INVESTIGATOR

Nancy P. Solomon, Ph.D.

PRINCIPAL_INVESTIGATOR

About this study

Background

A nonintrusive, inexpensive behavioral approach is emerging as a promising alternative to the management of obstructive sleep apnea (OSA). Generally referred to as myofunctional therapy (MFT), the approach involves exercising the muscles of the oropharynx and respiratory system.The exercises are intended to improve muscle strength and tone so that the muscular structures of the upper airway improve their neuromuscular responsiveness to breathing and resist collapsing into the airway during sleep. They are relatively simple to implement and train, but the regimen requires high-dosage practice and strict dedication to habituate. There is a need for an MFT protocol to be delivered in a consistent manner that is simple, sustainable, and motivating. This study takes advantage of recent low-tech tools that appear to elicit the desired muscle actions achieved with MFT.

Participant Recruitment

Participants are recruited from the Sleep Clinic at Walter Reed National Military Medical Center if they receive a new diagnosis of obstructive sleep apnea (AHI >5) based on standard-of-care polysomnography (PSG) or if they do not successfully use a standard first-line treatment. After providing informed consent and passing screening tests, they are randomized into one of two behavioral interventions.

Interviews will determine whether participants have a history of TBI. Participants in the two intervention arms will be block stratified based on +/- TBI and TBI severity. The groups will also be stratified based on OSA severity.

Interventions

The interventions involving drinking water through a study-provided water bottle with a specially designed nozzle and breathing in and out through a study-provided handheld breathing device multiple times daily for 3 months. Therefore, this novel intervention is called "HydroBreathe Therapy." The intervention arms are named for the color of the breathing device. Participants will be informed that the Green option involves exercises intended to relax airway structures and promote better airway patency, and that the Black option involves high-resistance exercises intended to increase airway muscle strength to resist structural collapse. Participants are not informed which of the options is expected to be more therapeutic, but they are informed that both may help and neither will worsen their OSA.

Participants will enter their daily practice into electronic adherence logs, which will be monitored by the study team. A study team member will contacted participants every 2 weeks throughout the intervention period to offer encouragement and answer questions.

Assessments

Pre- and post-intervention measures are obtained from PSG results, self-assessment questionnaires, and measures of tongue and respiratory muscle function. Participants in the experimental group will be given the option to participate in a 3-week follow-up assessment including the questionnaires and muscle-function testing if they are willing to delay first-line treatment for OSA. All participants will be referred back to the Sleep Clinic for standard treatment at the conclusion of the study.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • New diagnosis of OSA (AHI, ≥ 5) or failure of first-line OSA treatment;
  • Willingness to forego first-line OSA treatment or stop current OSA treatment for 3 months;
  • Ability to follow directions and perform the required exercises;
  • Age between 18-65 yr.

Exclusion criteria

  • Current use of OSA treatment;
  • Medical comorbidities that require restricting fluid intake (e.g., dysphagia, renal disease, liver disease, hyponatremia);
  • Severe nasal obstruction; 4) severe ankyloglossia; 4) craniofacial abnormality; 5) severe pulmonary disease; 6) severe post-traumatic stress disorder; 7) very severe insomnia; 8) body mass index (BMI) ≥30 kg/m2

Treatment and study plan

High-Resistance Breathing and Drinking Exercises

Behavioral

Three months of drinking at least 32-oz of water daily through a high-resistance nozzle, and inhaling and exhaling 60 times per day through a high-resistance breathing device

Other names: Device-Assisted Myofunctional Therapy

Low-Resistance Breathing and Drinking Exercises

Behavioral

Three months of drinking 32-oz of water daily through a low-resistance nozzle, and inhaling and exhaling 40 times per day through a low-resistance breathing device

Other names: Placebo Therapy

Primary outcomes

  1. Apnea-Hypopnea Index (AHI)

    Time frame: From enrollment to end of three-month intervention

    AHI is the number of apneic and hypopneic episodes per hour of sleep. The scores start at zero, meaning no events are taking place. A mild score falls in the range of 5-15; moderate 15-30, and a severe diagnosis is 30 or more events per hour. Pre-intervention AHI is obtained from standard-of-care in-clinic sleep study. Post-intervention AHI is obtained from an in-clinic sleep study conducted as part of this research.

Secondary outcomes

  1. SpO2

    Time frame: From enrollment to end of three-month intervention

    Oxygen saturation measured during the in-clinic sleep studies. Normal levels range between 95-100%.

  2. Snore Index

    Time frame: From enrollment to end of three-month intervention

    Number of snoring episodes per hour of sleep

  3. Epworth Sleepiness Scale (ESS)

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

    A self-assessment of daytime sleepiness comprising eight questions on a four-point scale (0-3; total range = 0-24). Higher scores indicate greater daytime sleepiness.

  4. Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10)

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

    A self-assessment of the impact of daytime sleepiness on daily activities. Of the 10 questions, five are rated 0-4 and five are rated 1-4, for a total score ranging between 5-40. A higher score indicates lower impact.

Other outcomes

  1. Tongue Strength

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

    The maximum pressure generated during tongue-to-palate compression of an air-filled bulb over three trials.

  2. Tongue Endurance

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

    The maximum duration of sustaining tongue-to-palate compression of an air-filled bulb at 50% of maximum pressure.

  3. Maximal Inspiratory Pressure (MIP)

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

    The maximum pressures generated during maximal-effort inspiration in cmH2O.

  4. Maximal Expiratory Pressure (MEP)

    Time frame: From enrollment to end of three-month intervention with option for additional three-week follow-up

    The maximum pressures generated during maximal-effort expiration in cmH2O.

Study contacts

Contact information is provided by the study sponsor or research team.

Kathleen M. Moran, Ed.D

CONTACT

[email protected]

Nancy P. Solomon, Ph.D.

CONTACT

[email protected]

301-319-7042

Sponsors and collaborators

Lead sponsor

Uniformed Services University of the Health Sciences

Fed

Registry information

Official study title

Myofunctional Therapy for Obstructive Sleep Apnea in U.S. Service Members With and Without Traumatic Brain Injury

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Dec 24, 2025
Registry last updated
Feb 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.